A new study reports people with Alzheimer's disease are more likely to use antipsychotic medications, and for longer periods of time, than the general public.
Sustained use of the antipsychotic olanzapine resulted in potentially adverse alterations in brain structure, specifically cortical thinning.
People with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications.
While England has only seen a moderate rise in people being diagnosed with psychosis in recent years, prescription rates for antipsychotic medications have doubled.
Study reveals a moderate link between antipsychotic use and an increased risk of developing breast cancer.
Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications.
Study reveals a link between people with depression who are prescribed newer antipsychotic medications and higher mortality risk.
According to a new study, antipsychotic medications could increase the risk of death in patients with Parkinson's disease psychosis.
A new study reports people with treatment resistant schizophrenia appear to have better outcomes when they are switched to clozapine rather than other antipsychotic medications.
A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.
The antipsychotic medication clozapine can trigger severe obsessive-compulsive symptoms (OCS) in patients. Adding aripiprazole can help manage clozapine-associated OCS.
